IBJNews

  • Home

Cancer drug developer Endocyte files for IPO

Scott Olson
August 18, 2010
Keywords
Drug discovery, Endocyte Inc., Health Care & Insurance, Health Care & Life Sciences, Health Care Businesses, Initial Public Offerings, Life Science & Biotech, Medical Research, Pharmaceutical, Public Companies, Regional News, Tippecanoe Co., West Lafayette
Back to TopCommentsE-mailPrint

Biopharmaceutical company Endocyte Inc., encouraged by the development of its cancer-fighting drugs, said Tuesday it has filed for an initial public offering.

The company, headquartered at Purdue University Park in West Lafayette, said the number of shares to be offered and their price range have yet to be determined.

Los Angeles-based Wedbush PacGrow Life Sciences and Milwaukee-based Baird will co-manage the offering.

Endocyte has a pipeline of drugs in development for the treatment of various cancers and inflammatory diseases, including six drugs in clinical trials.

At the World Conference on Lung Cancer in San Francisco last August, Endocyte announced positive results for its lead drug, EC145, in a Phase II non-small-cell lung cancer study.

And, in October, the company closed on $26 million in equity financing to help it continue developing the drugs.

Marcus Chandler, chairman of Barnes & Thornburg LLP’s entrepreneurial services practice group, said the IPO helps validate the state’s efforts to become a life sciences hub.

“Those [companies] that have been successful have merged into public companies,” he said, “so the Endocyte IPO is huge news and a huge step forward in creating credibility for our claim in Indiana to be a life sciences center.”

In any industry, IPOs always have been scarce in Indiana. Last year, there were just two. Evansville-based infant-formula-maker Mead Johnson Nutrition Co. staged a $782 million IPO in February, then promptly moved its headquarters to the Chicago area. In its December IPO, Carmel-based used-vehicle auctioneer KAR Auction Services Inc. raised $300 million.

Endocyte’s IPO is the third announced so far this year in Indiana. Fort Wayne-based Vera Bradley Inc., a handbag maker, filed plans last month to raise $175 million. Evansville-based UCI International, a supplier of replacement parts for the light- and heavy-duty vehicle aftermarket, said in July it plans to raise $200 million.

Nationally, the IPO market looks to be improving. So far this year 170 have been filed, topping the 119 filed in 2009 and the 153 in 2008.
 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

ADVANCED SEARCH
Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ

  1. First, the Athenaeum is going to have to get past the hurdle with the Lockerbie residents and the agreement that the parcel would be residential. Second, and in my opinion, this prime piece of property should include parking, PLUS, a black box theater(s), some market rate and affordable artist housing and a plan to renovate and reconfigure the second story theater. I would negotiate to add the DeHaan property surface parking lot into the development mix, place a one story surface parking garage on the DeHaan lot on the street level (for the Dehaan tenants use during the daytime) and add a second story to the garage that would become an addition to the current second story theater and then change the direction of the theater by moving the stage across the alley and on top of the DeHaan lot parking. You can add all the stage elements that are currently missing from the Athenaeum stage to make it more attractive for use by Ballet, Opera and traveling productions. Plus, the theater changes would probably help solve some of the soundproofing issues. Alas,it does not seem to be a part of the strategic plan to conduct a study to determine best use of the property. Seems like the current plan is a quick and easy move that ignores the property best use/potential and any strategic property planning for the effect on future generations.

  2. I recall that MSA's pilings are still in the ground and hard to remove. It’s not likely any proposal will include significant underground construction/parking because of this. Start adding 2 floors of retail, 8 floors of parking and 5-10 floors of possible hotel, and/or 10-20 floors of residential, and you are at 30 floors already with possible expansion of all the uses. But then again I could be wrong.

  3. Accoriding to their website there is no deadline to the Do Not Call list. What is this article referring to??

  4. On what planet are they entitled to this largesse from the stockholders? These people make multi-million dollar salaries: Pay for your own personal travel.

  5. It matters because they're already paid enormously fat salaries: Pay for your own personal travel. Being "taxed on it" isn't a valid excuse--so what? They're still being gifted a raft of luxury perks from somebody else's money on top of an enormous, lavish salary.

ADVERTISEMENT